Ropivacaine-iPr, identified by its CAS number 175888-75-2, is a local anesthetic belonging to the amide class of anesthetics. It is a derivative of ropivacaine, which is known for its use in regional anesthesia and pain management. The substance exhibits a high degree of lipophilicity, which enhances its ability to penetrate nerve membranes, thereby providing effective analgesia. Ropivacaine-iPr is characterized by a longer duration of action compared to other local anesthetics, making it suitable for various surgical and pain management applications. Its pharmacological profile includes a lower potential for cardiotoxicity and neurotoxicity, which is a significant advantage in clinical settings. The compound is typically administered via injection and is often used in epidural and peripheral nerve blocks. Additionally, it has a favorable safety profile, contributing to its popularity in both surgical and postoperative pain management. As with all anesthetics, careful dosing and monitoring are essential to minimize potential side effects and ensure patient safety.

Ropivacaine-iPr

175888-75-2: Ropivacaine-iPr, identified by its CAS number 175888-75-2, is a local anesthetic belonging to the amide class of anesthetics. It is a derivative of ropivacaine, which is known for its use in regional anesthesia and pain management. The substance exhibits a high degree of lipophilicity, which enhances its ability to penetrate nerve membranes, thereby providing effective analgesia. Ropivacaine-iPr is characterized by a longer duration of action compared to other local anesthetics, making it suitable for various surgical and pain management applications. Its pharmacological profile includes a lower potential for cardiotoxicity and neurotoxicity, which is a significant advantage in clinical settings. The compound is typically administered via injection and is often used in epidural and peripheral nerve blocks. Additionally, it has a favorable safety profile, contributing to its popularity in both surgical and postoperative pain management. As with all anesthetics, careful dosing and monitoring are essential to minimize potential side effects and ensure patient safety.

CAS 175888-75-2

Ropivacaine-iPr

(±)-N-(2,6-Dimethylphenyl)-1-iso-propyl-d7-2-piperidinecarboxamide

Ref: 3U-D6992